Simplex Trading
TRAW icon

Simplex Trading’s Traws Pharma TRAW Stock Holding History

Simplex Trading’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-176
Closed -$8K – 11303
2022
Q1 		$8K Hold
176
– – ﹤0.01% 9115
2021
Q4 		$11K Buy
+176
New +$14.2K ﹤0.01% 8971
2016
Q2 		– Hold
0
– -$2K – 6561
2016
Q1 		– Hold
0
– – – 4839
2015
Q2 		– Hold
0
– -$1K – 5968
2015
Q1 		– Hold
0
– – – 4646
2014
Q4 		– Hold
0
– – – 4327

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VWWMG
Vermillion & White Wealth Management Group Phoenixville, Pennsylvania $174M AUM 15.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Simplex Trading's TRAW Position: Q3 2024 in Review

Simplex Trading sold out of Traws Pharma (TRAW) in Q3 2024, closing a stake of 63 shares.

Simplex Trading first reported a position in TRAW in Q4 2021 and held it in 8 quarters. The position peaked at $27K in Q4 2021. 12 funds tracked by Wall St. Rank hold TRAW as of Q3 2024.

  • Simplex Trading reported no remaining Traws Pharma position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 63 Traws Pharma shares in Q3 2024.
  • Simplex Trading first reported a position in Traws Pharma in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's Traws Pharma position peaked at $27K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.